glycerylphosphorylcholine has been researched along with Chronic Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karaulov, AV; Konoplya, AI; Laskov, VB; Shul'ginova, AA | 1 |
| Musin, RS; Solonskiĭ, DS; Stulin, ID | 1 |
| Artemova, IIu; Boĭko, AN; Ganzhula, PA; Ismailov, AM; Khozova, AA; Kostenko, EV; Lisenker, LN; Otcheskaia, OV; Petrov, SV; Petrova, LV; Rotor, LD; Vdovichenko, TV | 1 |
| Arduini, A; Bonomini, M; Reale, M; Sirolli, V | 1 |
1 trial(s) available for glycerylphosphorylcholine and Chronic Disease
| Article | Year |
|---|---|
[The use of cerepro (choline alfoscerate) in the treatment of outpatients with chronic progressive cerebrovascular disease].
Topics: Aged; Aged, 80 and over; Ambulatory Care; Cerebrovascular Disorders; Chronic Disease; Drug Therapy, Combination; Female; Glycerylphosphorylcholine; Humans; Male; Middle Aged; Treatment Outcome | 2012 |
3 other study(ies) available for glycerylphosphorylcholine and Chronic Disease
| Article | Year |
|---|---|
[PHARMACOLOGICAL CORRECTION OF RED BLOOD CELL MEMBRANE LIPID SPECTRUM IN PATIENTS WITH CHRONIC CEREBRAL ISCHEMIA ON THE BACKGROUND OF HYPERTENSIVE DISEASE.]
Topics: Adult; Amino Acids; Brain Ischemia; Chronic Disease; Erythrocyte Membrane; Female; Glycerylphosphorylcholine; Heme; Humans; Hypertension; Male; Membrane Lipids; Middle Aged | 2016 |
[Choline alphoscerate (ceretone) in the treatment of patients with chronic cerebral ischemia].
Topics: Aged; Brain Ischemia; Chronic Disease; Cognition; Dose-Response Relationship, Drug; Electroencephalography; Female; Follow-Up Studies; Glycerylphosphorylcholine; Humans; Injections, Intravenous; Male; Middle Aged; Surveys and Questionnaires; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Doppler, Transcranial | 2009 |
Involvement of phosphatidylserine exposure in the recognition and phagocytosis of uremic erythrocytes.
Topics: Anemia; Cell Communication; Chemotaxis; Chronic Disease; Erythrocyte Aging; Erythrocyte Membrane; Erythrocytes; Female; Flow Cytometry; Glycerylphosphorylcholine; Humans; Macrophages; Male; Middle Aged; Phagocytosis; Phosphatidylcholines; Renal Dialysis; Uremia | 2001 |